期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
ARTEMETHER治疗疟疾87例疗效观察
1
作者 冯红军 《中外医疗》 2008年第21期96-,共1页
目的探讨ARTEMETHER治疗疟疾的临床效果。方法回顾性分析ARTEMETHER治疗疟疾的87例患者资料。结果各种类型痊愈63例,有效23例,无效1例。结论ARTEMETHER能控制疟疾发作和消除临床症状,而且其半衰期为9小时,不易产生耐药性,是目前较为理... 目的探讨ARTEMETHER治疗疟疾的临床效果。方法回顾性分析ARTEMETHER治疗疟疾的87例患者资料。结果各种类型痊愈63例,有效23例,无效1例。结论ARTEMETHER能控制疟疾发作和消除临床症状,而且其半衰期为9小时,不易产生耐药性,是目前较为理想的抗疟药物。 展开更多
关键词 artemether 疟疾 效果
下载PDF
Effect of artemether on hematological parameters of healthy and uninfected adult Wistar rats 被引量:1
2
作者 Osonuga IO Osonuga OA +2 位作者 Osonuga A Onadeko AA Osonuga AA 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2012年第6期493-495,共3页
Objective:To evaluate the effect of short term artemether administration on some blood parameters in adult male Wistar rats.Methods:Sixty five albino rats with body weight of 190-220 g were used for the four-phased st... Objective:To evaluate the effect of short term artemether administration on some blood parameters in adult male Wistar rats.Methods:Sixty five albino rats with body weight of 190-220 g were used for the four-phased study. The animals were randomly divided into five groups. The first-four groups of 15 rats were further divided into 3 subgroups of 5 rats. The drug was administered orally at sub-optimal, therapeutic, and high doses of 25, 50 and 75 mg/kg bw,respectively to the rats for 1 day, 2 days and 3 days. Blood samples were collected by cardio-puncture from the rats for hematology at the end of each phase. The last group served as control,and they were given waterad libitum.Results:Artemether caused significant reduction(P<0.05)of the hematological profile of the animals in a dose dependent manner. Discontinuation of the drug use however showed gradual recovery of the depressed indices of the blood parameters.Conclusions:The results suggest that artemether can induce reversible changes in hematological profiles of rats by extension man. This can probably aggravate anemia when artemether is administered to malaria patients. Hence, the study supports the use of the drug with cautione specially in patients prone to anemic tendencies. 展开更多
关键词 artemether ANEMIA ANTIMALARIA HEMATOLOGY HEMATOLOGICAL profile Malaria ANEMIC tendency
下载PDF
Exploring the potential of porous silicas as a carrier system for dissolution rate enhancement of artemether
3
作者 Jaywant N.Pawar Harita R.Desai +2 位作者 Kailas K.Moravkar Deepak K.Khanna Purnima D.Amin 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2016年第6期760-770,共11页
Malaria is a parasitic and vector determined blood-conceived infectious disease transmitted through infected mosquitoes. Anti-malarial drug resistance is a major health problem, which hinders the control of malaria. A... Malaria is a parasitic and vector determined blood-conceived infectious disease transmitted through infected mosquitoes. Anti-malarial drug resistance is a major health problem, which hinders the control of malaria. A Results of a survey of drug-resistant malaria demonstrated safe proclivity to nearby all anti-malarial regimes accessible except from artemisinin and its derivatives. Artemether is a BCS class IV drug effective against acute and severe falciparum malaria;hence there is a strong need to improve its solubility. Silica is one of the most widely studied excipients. Silica can be used in solubility enhancement by preparing its solid solution/dispersion with the drug. The objective of this research was to improve dissolution rate of Artemether using non-precipitated porous silica(Aeroperl 300 Pharma) and precipitated silica like EXP. 9555, EXP. 9560, and EXP. 9565. Specific surface area calculated from BET method of porous silicas viz. APL 300(A), Exp. 9555(B), Exp. 9560(C), Exp. 9565(D) was found to be 294.13 m^2/g(A), 256.02 m^2/g(B), 213.62 m^2/g(C) and 207.22 m^2/g(D) respectively.The drug release from the developed formulation was found to be significantly higher as compared to neat ARM. This improved solubility and release kinetics of ARM may be attributed to high surface area, improved wettability and decreased crystallinity. Solid-state characterization of the developed optimized formulation F3 was carried out with respect to FTIR chemical imaging, XRD,SEM, and DSC. All the porous silicas which we have explored in the present context showed a significant capability as a carrier for solubility enhancement of ARM. 展开更多
关键词 artemether SOLUBILITY Solid dispersion POROUS SILICA Aeropearl 300
下载PDF
Effect of Artemether Treatment on Plasma Lipid Profile in Malaria
4
作者 Nkereuwem Edikpo Paul Obiekwe Okonkwo Elias Adikwu 《Pharmacology & Pharmacy》 2014年第7期646-656,共11页
This study was undertaken to assess the effect of artemether treatment on plasma lipid profile in malaria infection. While the importance of lipid to plasmodial infective processes and metabolism is being increasingly... This study was undertaken to assess the effect of artemether treatment on plasma lipid profile in malaria infection. While the importance of lipid to plasmodial infective processes and metabolism is being increasingly appreciated, little is known about the attendant effect of chemotherapy on plasma lipid profile. Thirty patients with uncomplicated malaria were chosen from two secondary health-care facilities in Yobe State, Nigeria with informed consents and ethical clearance. Based on predetermined inclusion criteria patients were given 3.2 mg/kg of artemether with 1.6 mg/kg on subsequent days for a total of five days. This was done after the collection of urine and blood samples for urinalysis, malaria parasite density count and serum lipid analysis. A follow-up was planned seven (7) days from first dose during when clinical assessment and repeat malaria parasite density count and serum lipid analysis were done. Data were analyzed with statistical package for social scientist and Microsoft Excel spread sheet while level of significance at p ≤ 0.05 was calculated using paired t-test. Serum HDL cholesterol concentration recorded a significant decline of 0.13 mmol/L from a pre-treatment mean concentration of 1.17 mmol/L (p < 0.04). Triglyceride, total cholesterol, LDL-cholesterol, VLDL-cholesterol showed increment or reductions that were not significant. The clinical cure rate was 50% and mean percentage reduction in parasitaemia was 52%. A possible explanation for this low cure rate could be resistance, unfavorable pharmacokinetic disposition or lack of full adherence. A trial with complete parasite clearance, possibly using artemisinin-based combinational therapy would provide a more compelling result. 展开更多
关键词 artemether PLASMA LIPID PROFILE MALARIA Humans
下载PDF
Study on Method for Determination of Artemether Content in New Artemether Injection
5
作者 Bing LI Sihan WANG +1 位作者 Xuzheng ZHOU Jiyu ZHANG 《Agricultural Biotechnology》 CAS 2018年第3期174-177,共4页
This study was conducted to establish a high performance liquid chromatography( HPLC) method for the determination of artemether in the artemether injection using Hypersil ODS C18 chromatographic column( 5 μm,4. 6... This study was conducted to establish a high performance liquid chromatography( HPLC) method for the determination of artemether in the artemether injection using Hypersil ODS C18 chromatographic column( 5 μm,4. 6 mm × 150 mm). Mobile phase,column temperature,flow rate and detection wavelength were optimized. Acetonitrile-water-tetrahydrofuran( 62∶ 37∶ 1,V/V) was selected as the mobile phase,and the HPLC was performed with column temperature at30 ℃ and the flow rate at 1. 0 ml/min; and the detection wavelength was set at 216 nm. The HPLC detection system of artemether had good suitability. The linearity was good in 100-800 μg/ml concentration range,and the regression equation was y = 302. 36 x-682. 02,R2= 0. 999 8. The overall average recovery was97. 58%,and the RSD was 1. 58%. Three batches of artemether injection samples were determined by the method,showing RSD of 1. 42%. The method could be used for the detection of artemether content in artemether injection. 展开更多
关键词 artemether injection HPLC Content determination
下载PDF
AN EXPERIMENTAL TRIAL OF ARTEMETHER IN TREATMENT OF PNEUMOCYSTIS CARINII IN IMMUNOSUPPRESSED RATS
6
作者 陈雅棠 马良 +2 位作者 梅芹 唐宜 廖晓岗 《Chinese Medical Journal》 SCIE CAS CSCD 1994年第9期35-39,共5页
An immunosuppressed rat model was establisbed by injecting cortisone acetate 25 mg/rat twice a week for 4 weeks and 12.5mg/rat for another 2 weeks subcutaneously.A development of Pneumocystis carinii pneumonia(PCP) wa... An immunosuppressed rat model was establisbed by injecting cortisone acetate 25 mg/rat twice a week for 4 weeks and 12.5mg/rat for another 2 weeks subcutaneously.A development of Pneumocystis carinii pneumonia(PCP) was found at the end of the 6th week in all rats. 展开更多
关键词 AN EXPERIMENTAL TRIAL OF artemether IN TREATMENT OF PNEUMOCYSTIS CARINII IN IMMUNOSUPPRESSED RATS In
原文传递
青蒿素之母——2015年诺贝尔生理学或医学奖新科得主屠呦呦(二) 被引量:11
7
作者 朱安远 郭华珍 《中国市场》 2016年第14期186-194,共9页
2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国... 2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国内舆论媒体亢奋,国人无不欢欣鼓舞。屠呦呦先生是首位荣获诺贝尔科学奖的中国大陆本土科学家、首位华裔女性诺奖得主和诺医奖得主,这是中国医学界尤其是中医学界的重大历史性突破,这一荣耀将永远铭记在中国科技发展史上。详细介绍了屠呦呦女士的生平、主要学术成就与贡献、与疟疾直接相关的诺医奖以及青蒿素类抗疟药物获得的各种国内外奖项,简明扼要地阐述了青蒿素类抗疟药物的发现(发明)简史,不惜浓墨重彩全方位地展示了以屠呦呦为杰出代表的中国科学家群英谱的奋斗历程和辉煌成就。 展开更多
关键词 屠呦呦 寄生虫病 疟疾(malaria) 疟原虫 抗疟药物(antimalarial drug) 剂型 抗药性(耐药性) 中药 西药(化学药品) 青蒿 黄花蒿 青蒿素(artemisinin) 衍生物(derivative) 双氢青蒿素DHA(dihydroartemisinin) 蒿甲醚(artemether) 蒿乙醚(artemotil/arteether) 青蒿琥酯(artesunate) 卡罗琳医学院诺贝尔大会 生理学或医学奖诺贝尔委员会(医诺委) 诺贝尔生理学或医学奖(诺医奖)
下载PDF
青蒿素之母——2015年诺贝尔生理学或医学奖新科得主屠呦呦(一) 被引量:10
8
作者 朱安远 郭华珍 《中国市场》 2016年第9期199-208,共10页
2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国... 2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国内舆论媒体亢奋,国人无不欢欣鼓舞。屠呦呦先生是首位荣获诺贝尔科学奖的中国大陆本土科学家、首位华裔女性诺奖得主和诺医奖得主,这是中国医学界尤其是中医学界的重大历史性突破,这一荣耀将永远铭记在中国科技发展史上。详细介绍了屠呦呦女士的生平、主要学术成就与贡献、与疟疾直接相关的诺医奖以及青蒿素类抗疟药物获得的各种国内外奖项,简明扼要地阐述了青蒿素类抗疟药物的发现(发明)简史,不惜浓墨重彩全方位地展示了以屠呦呦为杰出代表的中国科学家群英谱的奋斗历程和辉煌成就。 展开更多
关键词 屠呦呦 寄生虫病 疟疾(malaria) 疟原虫 抗疟药物(antimalarial drug) 剂型 抗药性(耐药性) 中药 西药(化学药品) 青蒿 黄花蒿 青蒿素(artemisinin) 衍生物(derivative) 双氢青蒿素DHA(dihydroartemisinin) 蒿甲醚(artemether) 蒿乙醚(artemotil/arteether) 青蒿琥酯(artesunate) 卡罗琳医学院诺贝尔大会 生理学或医学奖诺贝尔委员会(医诺委) 诺贝尔生理学或医学奖(诺医奖)
下载PDF
青蒿素之母——2015年诺贝尔生理学或医学奖新科得主屠呦呦(四) 被引量:9
9
作者 朱安远 郭华珍 《中国市场》 2016年第22期260-272,共13页
2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国... 2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国内舆论媒体亢奋,国人无不欢欣鼓舞。屠呦呦先生是首位荣获诺贝尔科学奖的中国大陆本土科学家、首位华裔女性诺奖得主和诺医奖得主,这是中国医学界尤其是中医学界的重大历史性突破,这一荣耀将永远铭记在中国科技发展史上。详细介绍了屠呦呦女士的生平、主要学术成就与贡献、与疟疾直接相关的诺医奖以及青蒿素类抗疟药物获得的各种国内外奖项,简明扼要地阐述了青蒿素类抗疟药物的发现(发明)简史,不惜浓墨重彩全方位地展示了以屠呦呦为杰出代表的中国科学家群英谱的奋斗历程和辉煌成就。 展开更多
关键词 屠呦呦 寄生虫病 疟疾(malaria) 疟原虫 抗疟药物(antimalarial drug) 剂型 抗药性(耐药性) 中药 西药(化学药品) 青蒿 黄花蒿 青蒿素(artemisinin) 衍生物(derivative) 双氢青蒿素DHA(dihydroartemisinin) 蒿甲醚(artemether) 蒿乙醚(artemotil/arteether) 青蒿琥酯(artesunate) 卡罗琳医学院诺贝尔大会 生理学或医学奖诺贝尔委员会(医诺委) 诺贝尔生理学或医学奖(诺医奖)
下载PDF
青蒿素之母——2015年诺贝尔生理学或医学奖新科得主屠呦呦(三) 被引量:8
10
作者 朱安远 郭华珍 《中国市场》 2016年第18期233-245,共13页
2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国... 2015年10月5日,中国中医科学院(原中国中医研究院)终身研究员兼首席研究员、女药学家、药物化学家、医学家和教育家屠呦呦以创制新型抗疟药物——青蒿素及其首个衍生物双氢青蒿素而赢得当年诺贝尔生理学或医学奖之殊荣,特大喜讯传来,国内舆论媒体亢奋,国人无不欢欣鼓舞。屠呦呦先生是首位荣获诺贝尔科学奖的中国大陆本土科学家、首位华裔女性诺奖得主和诺医奖得主,这是中国医学界尤其是中医学界的重大历史性突破,这一荣耀将永远铭记在中国科技发展史上。详细介绍了屠呦呦女士的生平、主要学术成就与贡献、与疟疾直接相关的诺医奖以及青蒿素类抗疟药物获得的各种国内外奖项,简明扼要地阐述了青蒿素类抗疟药物的发现(发明)简史,不惜浓墨重彩全方位地展示了以屠呦呦为杰出代表的中国科学家群英谱的奋斗历程和辉煌成就。 展开更多
关键词 屠呦呦 寄生虫病 疟疾(malaria) 疟原虫 抗疟药物(antimalarial drug) 剂型 抗药性(耐药性) 中药 西药(化学药品) 青蒿 黄花蒿 青蒿素(artemisinin) 衍生物(derivative) 双氢青蒿素DHA(dihydroartemisinin) 蒿甲醚(artemether) 蒿乙醚(artemotil/arteether) 青蒿琥酯(artesunate) 卡罗琳医学院诺贝尔大会 生理学或医学奖诺贝尔委员会(医诺委) 诺贝尔生理学或医学奖(诺医奖)
下载PDF
抗疟疾复方制剂--COARTEM~ 被引量:4
11
作者 孙卫华 《中国药师》 CAS 2006年第10期965-966,共2页
COARTEM@(COA)是由诺华公司研制生产的首个抗疟疾复方制剂,临床用于恶性疟疾,作用迅速可靠,使用安全方便。2002年4月已被WHO“基本药物目录”收载。本品每片含蒿甲醚(ART)20mg,本芴醇(LUM)120mg。
关键词 COARTEM@ 蒿甲醚(artemether) 本芴醇(Lumefantrine) 抗疟疾治疗
原文传递
Resolution pattern of jaundice among children presenting with severe malaria in rural South-West Nigeria 被引量:1
12
作者 Osonuga OA Osonuga A +1 位作者 Osonuga AA Osonuga IO 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2012年第7期551-553,共3页
Objective:To compare the pattern of jaundice resolution among children with severe malaria treated with quinine and artemether.Methods:Thirty two children who fulfilled the inclusion criteria were recruited for the st... Objective:To compare the pattern of jaundice resolution among children with severe malaria treated with quinine and artemether.Methods:Thirty two children who fulfilled the inclusion criteria were recruited for the study from two hospitals with intensive care facilities.They were divided into two groups:'Q' and 'A',receiving quinine and artemether.respectively.Jaundice was assessed by clinical examination.Results:Sixteen out of 32 children recruited(representing50%) presented with jaundice on the dav of recruitment.The mean age was(7.00±2.56) years.On day 3,tour patients in 'A' and six patients in 'O' had jaundice.By day 7.no child had jaundice.Conclusion:The study has shown that hoth drugs resolve jaundice although artemether relatively resolves it faster by the third day. 展开更多
关键词 JAUNDICE Quinine artemether Severe malaria South-west NIGERIA
下载PDF
Effect of artmether,hemin and Fe^(3+) on recombinant lactate dehydrogenase from Schistosoma japonicum 被引量:1
13
作者 Gang Lu Xuchu Hu +5 位作者 Can Huang Yajun Lu Lixian Wu Lihua Li Jing Xu Xinbing Yu 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2010年第12期930-933,共4页
Objective:To explore antischitosome effects of artemether,hemin and Fe on S/LDH.Methods: Enzyme activity of rS/LDH was assayed in the standard reaction system by adding different concentration of reagents(0.00-0.10 mM... Objective:To explore antischitosome effects of artemether,hemin and Fe on S/LDH.Methods: Enzyme activity of rS/LDH was assayed in the standard reaction system by adding different concentration of reagents(0.00-0.10 mM artemether,0.00-0.02 mM hemin,0.00-0.50 mM Fe^(3+)). Same solvents of the each reagent were used as control.Results:There was no enzyme activity inhibition observed at 0.10 mM artemther:obivious inhibition for lactate oxidation reaction and pyruvate reduction reaction were detected at 0.002 mM and 0.004 mM of hemin,respectively: comparing with that of the control(P<0.05).The relative enzymatic activity inhibitions for pyruvate reduction reaction and lactate oxidation reaction at 0.02 mM hemin were 93.48%and 100.00%,respectively,comparing with that of the control(P<0.01):both pyruvate reduction and lactate oxidation reaction were inhibited completely at 0.50 mM Fe^(3+),comparing with that of the control(P<0.01).Conclusions:The results implied that SjLDH was not the direct molecular target of artemether.Hemin and Fe are inhibitors of SjLDH. 展开更多
关键词 Schistosoma japonicum Lactate dehydrogenase Recombinant protein artemether HEMIN Fe^(3+)
下载PDF
Artemisinin anti-malarial drugs in China 被引量:13
14
作者 Zongru Guo 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第2期115-124,共10页
Discovered by Youyou Tu, one of the 2015 Nobel Prize winners in Physiology or Medicine, together with many other Chinese scientists, artemisinin, artemether and artesunate, as well as other artemisinins, have brought ... Discovered by Youyou Tu, one of the 2015 Nobel Prize winners in Physiology or Medicine, together with many other Chinese scientists, artemisinin, artemether and artesunate, as well as other artemisinins, have brought the global anti-malarial treatment to a new era, saving millions of lives all around the world for the past 40 years. The discoveries of artemisinins were carried out beginning from the 1970s, a special period in China, by hundreds of scientists all together under the 'whole nation' system. This article focusing on medicinal chemistry research, briefly introduced the discovery and invention course of the scientists according to the published papers, and highlighted their academic contribution and achievements. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. 展开更多
关键词 ANTIMALARIAL ARTEMISININ artemether ARTESUNATE DIHYDROARTEMISININ
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部